DrugDashboards

Olmesartan Medoxomil

Olmesartan Medoxomil · OLMESARTAN MEDOXOMIL 5 mg/1 · Tablet · Oral · Lifestar Pharma LLC

NDC 70756-0808-30 · 30 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

10 companies supply this market — deep enough that no single failure threatens the supply. The price is down 15% over the past year, to $0.0622 per unit.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$0.2569per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.1951per TABweighted avg manufacturer price $0.1115 · Nov 1, 2022

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2$0.3Aug 2020Feb 2023$0.0622
31 price points · per · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$7.50
Reported to Texas DSHS · 2022 annual filing · Lifestar Pharma

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for olmesartan medoxomil (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA207135
TE code
AB
Approval date
Jul 18, 2019
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Olmesartan Medoxomil (Tablet)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Direct_rxOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLC.OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLC.OLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLC.OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.OLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCOLMESARTAN MEDOXOMIL 5 mg/1Aug 8, 2026Aug 29, 2026
NorthStar RxLLCOLMESARTAN MEDOXOMIL 40 mg/1Aug 8, 2026Aug 29, 2026
NorthStar RxLLCOLMESARTAN MEDOXOMIL 20 mg/1Aug 8, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olmesartan Medoxomil — NDC 70756-0808-30," retrieved September 3, 2026, https://drugdashboards.com/drug/70756080830.

Free to cite with attribution — see how the data is put together.